This forecasting study analyzes the impact of the Inflation Reduction Act (IRA) on diabetes drug costs for Medicare in Louisiana, USA. It finds that price negotiations for three non-insulin drugs are ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback